The fixed dosage combination of the risk of method or reduction cardiovascular disease including ETC1002 and ezetimibe and processing and formula

• 收藏
• 分享

专利权人:

Esperion Therapeutics; Inc.

发明人:

NEWTON, Roger, Schofield,ROSENBERG, Noah Laban,MACDOUGALL, Diane Elaine

申请号：

EP16765550

公开号：

EP3267989A4

申请日:

2016.03.14

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

Disclosed herein is the fixed dosages that composition includes ETC-1002 and ezetimibe. Equally disclosed herein is the methods for using the fixed dosage of ETC-1002 and ezetimibe. Use the risk of cardiovascular disease of the method or reduction for including treating cardiovascular disease in a main body. Use the method for further including the processing hypercholesterinemia in a kind of main body.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/